Cargando…
Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes
OBJECTIVE: The purpose of the study is to evaluate the effects of anticardiolipin (aCL) and/or anti-β2-glycoprotein-I (aβ2GPI) antibodies, namely antiphospholipid antibodies (aPL), on in vitro fertilization (IVF) outcomes. MATERIALS AND METHODS: The study group comprised infertile women with aPL und...
Autores principales: | Wu, Li, Fang, Xuhui, Lu, Fangting, Zhang, Yu, Wang, Yanshi, Kwak-Kim, Joanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667022/ https://www.ncbi.nlm.nih.gov/pubmed/36405731 http://dx.doi.org/10.3389/fimmu.2022.986893 |
Ejemplares similares
-
Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
por: Kang, H. J., et al.
Publicado: (1998) -
Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
por: Vanoverschelde, Laura, et al.
Publicado: (2019) -
Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
por: Melayah, Sarra, et al.
Publicado: (2022) -
No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis
por: Wang, Le, et al.
Publicado: (2021) -
Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19
por: Garcia-Arellano, Gisela, et al.
Publicado: (2023)